These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30707344)

  • 1. Unmasking neurobiological commonalities between addictive disorders and impulse control disorders in Parkinson's disease.
    Ramdave S; Dawson A; Carter A; Dissanayaka NNW
    Brain Imaging Behav; 2020 Dec; 14(6):2785-2798. PubMed ID: 30707344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging impulse control disorders in Parkinson's disease and their relationship to addiction.
    Ray NJ; Strafella AP
    J Neural Transm (Vienna); 2013 Apr; 120(4):659-64. PubMed ID: 23232664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
    J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study.
    Leplow B; Renftle D; Thomas M; Michaelis K; Solbrig S; Maetzler W; Berg D; Liepelt-Scarfone I
    J Neural Transm (Vienna); 2023 Feb; 130(2):125-133. PubMed ID: 36662280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.
    Pellicano C; Niccolini F; Wu K; O'Sullivan SS; Lawrence AD; Lees AJ; Piccini P; Politis M
    J Neurol; 2015 Dec; 262(12):2653-61. PubMed ID: 26410743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.
    Béreau M; Fleury V; Bouthour W; Castrioto A; Lhommée E; Krack P
    Rev Neurol (Paris); 2018 Nov; 174(9):653-663. PubMed ID: 30224159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
    O'Sullivan SS; Evans AH; Lees AJ
    CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Imaging and Impulse Control Disorders in Parkinson's Disease.
    Roussakis AA; Lao-Kaim NP; Piccini P
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):67. PubMed ID: 31396719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders.
    Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
    Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
    Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Tessitore A; De Micco R; Giordano A; di Nardo F; Caiazzo G; Siciliano M; De Stefano M; Russo A; Esposito F; Tedeschi G
    Mov Disord; 2017 Dec; 32(12):1710-1719. PubMed ID: 28949049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging behavioural complications of Parkinson's disease.
    Valli M; Mihaescu A; Strafella AP
    Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson's disease.
    Maggi G; Loayza F; Vitale C; Santangelo G; Obeso I
    J Neurol; 2024 May; 271(5):2798-2809. PubMed ID: 38416170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.
    Maréchal E; Denoiseux B; Thys E; Crosiers D; Pickut B; Cras P
    J Neurol; 2015 Jan; 262(1):7-20. PubMed ID: 24824224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.
    Vriend C
    Cell Tissue Res; 2018 Jul; 373(1):327-336. PubMed ID: 29383446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.